BMC Medical Co. Ltd. A (301367) - Net Assets
Based on the latest financial reports, BMC Medical Co. Ltd. A (301367) has net assets worth CN¥2.94 Billion CNY (≈ $429.59 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.52 Billion ≈ $515.61 Million USD) and total liabilities (CN¥587.83 Million ≈ $86.02 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check BMC Medical Co. Ltd. A asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.94 Billion |
| % of Total Assets | 83.32% |
| Annual Growth Rate | 65.92% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 182.01 |
BMC Medical Co. Ltd. A - Net Assets Trend (2020–2024)
This chart illustrates how BMC Medical Co. Ltd. A's net assets have evolved over time, based on quarterly financial data. Also explore total assets of BMC Medical Co. Ltd. A for the complete picture of this company's asset base.
Annual Net Assets for BMC Medical Co. Ltd. A (2020–2024)
The table below shows the annual net assets of BMC Medical Co. Ltd. A from 2020 to 2024. For live valuation and market cap data, see BMC Medical Co. Ltd. A stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.84 Billion ≈ $415.22 Million |
+1.82% |
| 2023-12-31 | CN¥2.79 Billion ≈ $407.82 Million |
+6.49% |
| 2022-12-31 | CN¥2.62 Billion ≈ $382.96 Million |
+432.71% |
| 2021-12-31 | CN¥491.28 Million ≈ $71.89 Million |
+31.22% |
| 2020-12-31 | CN¥374.40 Million ≈ $54.79 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to BMC Medical Co. Ltd. A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 299.5% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥996.45 Million | 35.23% |
| Other Components | CN¥1.83 Billion | 64.77% |
| Total Equity | CN¥2.83 Billion | 100.00% |
BMC Medical Co. Ltd. A Competitors by Market Cap
The table below lists competitors of BMC Medical Co. Ltd. A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Villar
TA:VILR
|
$869.90 Million |
|
Osisko Development Corp
V:ODV
|
$870.11 Million |
|
Lloyds Engineering Works Limited
NSE:LLOYDSENGG
|
$870.15 Million |
|
Gansu Guofang Gongmao(Grp)
SHG:601086
|
$870.29 Million |
|
Guangdong Great River Smarter Logistics Co Ltd Class A
SHE:002930
|
$869.62 Million |
|
Mega Lifesciences Public Company Limited
BK:MEGA-R
|
$869.61 Million |
|
Jiangsu Lianyungang Port Co Ltd
SHG:601008
|
$869.60 Million |
|
Lotte Reit Co Ltd
KO:330590
|
$869.49 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in BMC Medical Co. Ltd. A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,779,290,336 to 2,828,264,283, a change of 48,973,948 (1.8%).
- Net income of 155,382,242 contributed positively to equity growth.
- Dividend payments of 65,794,519 reduced retained earnings.
- Other factors decreased equity by 40,613,775.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥155.38 Million | +5.49% |
| Dividends Paid | CN¥65.79 Million | -2.33% |
| Other Changes | CN¥-40.61 Million | -1.44% |
| Total Change | CN¥- | 1.76% |
Book Value vs Market Value Analysis
This analysis compares BMC Medical Co. Ltd. A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.10x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 11.91x to 2.10x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2020-12-31 | CN¥5.57 | CN¥66.33 | x |
| 2021-12-31 | CN¥7.31 | CN¥66.33 | x |
| 2022-12-31 | CN¥29.13 | CN¥66.33 | x |
| 2023-12-31 | CN¥31.02 | CN¥66.33 | x |
| 2024-12-31 | CN¥31.57 | CN¥66.33 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently BMC Medical Co. Ltd. A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.49%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 18.42%
- • Asset Turnover: 0.25x
- • Equity Multiplier: 1.21x
- Recent ROE (5.49%) is below the historical average (24.26%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2020 | 60.86% | 40.65% | 1.20x | 1.25x | CN¥190.42 Million |
| 2021 | 29.65% | 21.99% | 1.06x | 1.27x | CN¥96.55 Million |
| 2022 | 14.57% | 26.87% | 0.48x | 1.12x | CN¥119.30 Million |
| 2023 | 10.70% | 26.49% | 0.38x | 1.05x | CN¥19.41 Million |
| 2024 | 5.49% | 18.42% | 0.25x | 1.21x | CN¥-127.44 Million |
Industry Comparison
This section compares BMC Medical Co. Ltd. A's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $3,882,684,540
- Average return on equity (ROE) among peers: 11.03%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| BMC Medical Co. Ltd. A (301367) | CN¥2.94 Billion | 60.86% | 0.20x | $869.67 Million |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $858.96 Million | 5.81% | 3.43x | $523.48 Million |
| Blue Sail Medical Co Ltd (002382) | $9.55 Billion | -5.95% | 0.64x | $1.10 Billion |
| Andon Health Co Ltd (002432) | $21.49 Billion | 7.76% | 0.23x | $5.00 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $3.21 Billion | 3.44% | 0.58x | $1.28 Billion |
| Guangzhou Improve Med Instrument (300030) | $838.26 Million | 3.10% | 0.80x | $376.43 Million |
| QITIAN Technology Group Co Ltd (300061) | $451.92 Million | 8.13% | 0.70x | $924.78 Million |
| Shanghai Tofflon Science Tech (300171) | $113.69 Million | 40.44% | 1.35x | $1.47 Billion |
| Truking Technology Ltd (300358) | $1.67 Billion | 8.57% | 0.72x | $1.02 Billion |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $122.42 Million | 28.61% | 0.63x | $770.09 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $520.95 Million | 10.42% | 0.38x | $2.50 Billion |
About BMC Medical Co. Ltd. A
BMC Medical Co., Ltd. researches, develops, manufactures, and supplies medical equipment and consumable in the field of respiratory health in China. It offers sleep-disordered breathing (SDB) diagnostic devices, non-invasive ventilators, high-flow nasal cannula oxygen therapy devices, oxygen concentrator, and respiratory consumables, such as various types of masks, breathing tubes, etc., as well … Read more